Greek pharma sector bemoans accumulation of debts

27 February 2012

The Greek pharmaceutical industry association, the SFEE, says that pharmaceutical companies may go out of business in the event of a “haircut” of the bonds they have acquired in settlement of overdue hospital debts. There is a noticeable risk of shortages in the supply of medicine.

Debts accumulated at the nation’s largest Social Security Organization (IKA) and military hospitals have reached explosive levels, coming close to 500 million euros ($658 million). The SFEE is sounding a note of warning that, unless the government addresses the problem very soon, the supply to these institutions with pharmaceuticals will be in immediate danger.

EU call for 1.1 billion-euro cut in drug spending

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical